10-87863421-CCCCTGCCCTG-CCCCTGCCCTGCCCTG
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_001126049.2(KLLN):c.-939_-935dupCAGGG variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000121 in 370,652 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.00020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000069 ( 0 hom. )
Consequence
KLLN
NM_001126049.2 5_prime_UTR
NM_001126049.2 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.159
Genes affected
KLLN (HGNC:37212): (killin, p53 regulated DNA replication inhibitor) The protein encoded by this intronless gene is found in the nucleus, where it can inhibit DNA synthesis and promote S phase arrest coupled to apoptosis. The expression of this DNA binding protein is upregulated by transcription factor p53. [provided by RefSeq, Dec 2012]
PTEN (HGNC:9588): (phosphatase and tensin homolog) This gene was identified as a tumor suppressor that is mutated in a large number of cancers at high frequency. The protein encoded by this gene is a phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase. It contains a tensin like domain as well as a catalytic domain similar to that of the dual specificity protein tyrosine phosphatases. Unlike most of the protein tyrosine phosphatases, this protein preferentially dephosphorylates phosphoinositide substrates. It negatively regulates intracellular levels of phosphatidylinositol-3,4,5-trisphosphate in cells and functions as a tumor suppressor by negatively regulating AKT/PKB signaling pathway. The use of a non-canonical (CUG) upstream initiation site produces a longer isoform that initiates translation with a leucine, and is thought to be preferentially associated with the mitochondrial inner membrane. This longer isoform may help regulate energy metabolism in the mitochondria. A pseudogene of this gene is found on chromosome 9. Alternative splicing and the use of multiple translation start codons results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAd4 at 30 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KLLN | ENST00000445946.5 | c.-939_-935dupCAGGG | 5_prime_UTR_variant | 1/1 | 6 | NM_001126049.2 | ENSP00000392204.2 | |||
PTEN | ENST00000693560 | c.-514_-510dupGCCCT | 5_prime_UTR_variant | 1/10 | ENSP00000509861.1 | |||||
PTEN | ENST00000688308.1 | c.-17+323_-17+327dupGCCCT | intron_variant | ENSP00000508752.1 | ||||||
PTEN | ENST00000693560.1 | c.-529_-528insCCCTG | upstream_gene_variant | ENSP00000509861.1 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152184Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
30
AN:
152184
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000687 AC: 15AN: 218352Hom.: 0 Cov.: 0 AF XY: 0.0000721 AC XY: 8AN XY: 110980
GnomAD4 exome
AF:
AC:
15
AN:
218352
Hom.:
Cov.:
0
AF XY:
AC XY:
8
AN XY:
110980
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000197 AC: 30AN: 152300Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74486
GnomAD4 genome
AF:
AC:
30
AN:
152300
Hom.:
Cov.:
32
AF XY:
AC XY:
16
AN XY:
74486
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Aug 22, 2024 | The PTEN c.-1034_-1030dup variant has been reported in the published literature in a study of patients with PTEN variants who had available brain magnetic resonance imaging (MRI), the patient who was positive for the variant showed no discrete malformation of cortical development (PMID: 32959437 (2020)). The frequency of this variant in the general population, 0.00058 (5/8680 chromosomes in African/African American subpopulation (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is higher than would generally be expected for pathogenic variants in this gene. Based on the available information, we are unable to determine the clinical significance of this variant. - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Sep 11, 2019 | Has not been previously published as pathogenic or benign to our knowledge; Variants within the PTEN promoter have been observed in individuals with features of Cowden syndrome (Zhou 2003); Also known as c.-1033_-1029dupGCCCT; This variant is associated with the following publications: (PMID: 12844284, 22679820) - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 28, 2023 | Variant summary: PTEN c.-1034_-1030dupGCCCT is located in the untranslated mRNA region upstream of the initiation codon, and involves the insertion of five nucleotides in the PTEN promoter region; variants in this region might alter transcription, which could result in impaired mRNA expression. PTEN is unique in that its promoter and its 5 UTR overlap, so variants in this region might also affect mRNA splicing and protein translation. The variant allele was found at a frequency of 0.00012 in 370652 control chromosomes (gnomAD v4.0.0). The observed variant frequency is approximately 19 fold of the estimated maximal expected allele frequency for a pathogenic variant in PTEN causing Cowden Syndrome phenotype (6.3e-06),, suggesting that the variant may be benign. To our knowledge, no occurrence of c.-1034_-1030dupGCCCT in individuals affected with PTEN-related disorders and no experimental evidence demonstrating its impact on protein function have been reported. The following publication was ascertained in the context of this evaluation (PMID: 32959437). Two submitters have reported clinical-significance assessments for this variant to ClinVar after 2014. Both submitters classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly benign. - |
Hereditary cancer-predisposing syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 16, 2013 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at